跳至主要内容
临床试验/NCT02187289
NCT02187289已完成不适用

Night-time Compression for Breast Cancer Related Lymphedema (LYNC): A Randomized Controlled Efficacy Trial

AHS Cancer Control Alberta3 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2014年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
120
试验地点
3
主要终点
Arm volume. Lymphedema will be objectively measured using the Perometer (Pero-systems, Wipputal, Germany)

研究概览

简要总结

Lymphedema (significant arm swelling on the surgical side) is one of the most common complications following treatment for breast cancer. The impact of lymphedema is profound, resulting in negative self image, increased anxiety and poorer quality of life. In time, lymphedema can result in recurrent infections in the arm, functional impairment and pain. Approximately 21% of women who undergo breast cancer treatment develop lymphedema. Unfortunately this is a life-time condition which tends to worsen over time. Currently, treatment consists of intensive physiotherapy, meant to reduce the arm volume followed by the wearing of compression sleeves during the day for maintenance. This study hopes to show that the addition of night-time compression creates a measurable reduction in arm volume and that adding night-time compression to the standard care (daytime compression only) will produce improvements in quality of life for breast cancer survivors.

详细描述

Lymphedema is a lifetime condition which tends to worsen over time, affecting roughly 21% of of treated breast cancer patients. An initial intensive rehabilitative treatment is usually prescribed to reduce the lymphedema, followed by a maintenance program using compression sleeves (Standard Care). However, compression sleeves are prescribed for daytime use only due to the potential tourniquet effect of the sleeve rolling up or bunching during the night.

Compression Bandages (short stretch, low elasticity) can be used at night but proper application takes 20-30 minutes, require skill to apply properly and are costly. Various types of night-compression system garments (NCSGs) have been designed as alternatives to Compression Bandages (CB).

The objectives of this study are to determine:

  1. Whether the addition of night-time compression (using CB or NCSG) to standard care (daytime compression only) improves control of arm lymphedema.
  2. Whether the use of NCSGs result in better outcomes in quality of life, sleep, treatment compliance and patient independence than use of Compression Bandages.

The hypotheses are that:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

性别
Female
接受健康志愿者
否

入选标准

  • •Histological diagnosis of breast cancer with mild to moderate lymphedema (minimum of 200 mls or 10% and maximum 40% increase in arm volume over the unaffected arm.)
  • •Completion of all primary and adjuvant cancer treatments (with exception of endocrine treatment) 1 month prior to randomization.
  • •In or entering upon the maintenance phase of lymphedema treatment.
  • •Have properly fitted day-time compression sleeve and agree to wear sleeve for the 12 hour per day standard of care period
  • •No current use of night-time compression (one month wash-out period before trial entry)

排除标准

  • •Clinical or radiological evidence of active disease, either local or metastatic
  • •History or clinical diagnosis of bilateral arm lymphedema
  • •Anyone for whom compression is contraindicated, such as those with untreated infections, skin irritations/rash, or thrombosis of the affected arm
  • •Serious non-malignant disease or any disorder/circumstance (psychiatric or addictive disorder) which would preclude consent/adherence to the protocol
  • •Unable to comply with the protocol, measurement and follow-up schedule due to factors such as vacation during the study period

研究组 & 干预措施

Standard care

Active Comparator

Weeks 1-12, Standard Care only (Compression Sleeve, daytime wear)

干预措施: Compression Sleeve, daytime wear (Device)

Standard Care plus Night-time Compression Bandages

Experimental

Weeks 1 - 12, Daytime compression sleeve plus night-time compression by self-administered or assisted multi-layered Compression Bandages.

干预措施: Night-time compression bandages (Device)

Standard Care plus Night-time Compression Bandages

Experimental

Weeks 1 - 12, Daytime compression sleeve plus night-time compression by self-administered or assisted multi-layered Compression Bandages.

干预措施: Compression Sleeve, daytime wear (Device)

Standard Care Plus Night-time Compression System Garment

Experimental

Weeks 1 - 12, Standard care (day-time sleeve) plus night-time use of a custom-made Night-time Compression System Garment

干预措施: Compression Sleeve, daytime wear (Device)

Standard Care Plus Night-time Compression System Garment

Experimental

Weeks 1 - 12, Standard care (day-time sleeve) plus night-time use of a custom-made Night-time Compression System Garment

干预措施: Night-time Compression custom-made garment (Device)

结局指标

主要结局

Arm volume. Lymphedema will be objectively measured using the Perometer (Pero-systems, Wipputal, Germany)

时间窗: 12 weeks

次要结局

  • Arm fluid. Bioimpedance analysis (BIA) will be used to assess extracellular fluid status within the arm(12 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验